About Samarind
Samarind is a company based in Deeside (United Kingdom) founded in 1987 was acquired by Instem in May 2016. The company has 436 employees. Samarind operates in a competitive market with competitors including RIMSYS, ValGenesis, Sware, Virtify and 3Aware, among others.
- Headquarter Deeside, United Kingdom
- Employees 436
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website samarindrms.com
- Social LinkedIn X
- Acquired by Instem (May 2016)
- Legal Name Instem Limited
- Date of Incorporation 05 Feb, 2010
- Jurisdiction STONE, STAFFORDSHIRE
Investors in Samarind
Samarind has secured backing from 1 investor. Prominent investors backing the company include Instem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Software for life science data collection and analysis is provided. | 1969 | instem.com | Conshohocken, United States |
Investor details for Samarind
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Samarind
2 dated milestones of Samarind across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Samarind is founded.
- Exit Acquired by Instem.
Competitors of Samarind
Samarind operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RIMSYS, ValGenesis, Sware, Virtify and 3Aware, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rimsys.io | 2017 | Pittsburgh, United States | $25.8M | 31 | Medical device regulatory management software is provided for healthcare organizations. | |
| valgenesis.com | 2005 | Fremont, United States | $24.0M | 431 | Validation software is provided for life sciences companies. | |
| sware.com | 2015 | Chelsea, United States | $24.4M | – | Validation automation platform for regulated systems is provided. | |
| virtify.com | 2004 | Cambridge, United States | $23.5M | 23 | Delivers content and compliance management software solutions. | |
| 3aware.ai | 2022 | Indianapolis, United States | $2.1M | – | Provider of real-world evidence platform for MedTech device safety and performance | |
| essenvia.com | 2018 | Los Angeles, United States | $5.5M | – | Software for medical device pre- and post-market workflows is provided. | |
| netregulus.com | 1999 | Boston, United States | $13.4M | – | Quality and regulatory data management solutions for life sciences industry | |
| targethealth.com | 1993 | New York, United States | – | 85 | Full-service clinical research organization software and services are provided. |
Detailed competitors of Samarind
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Samarind
10 companies that operate in the same segment as Samarind (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Samarind
Samarind was founded in 1987.
Samarind is headquartered in Deeside, United Kingdom. It is registered at Deeside, Wales, United Kingdom.
Samarind has 436 employees.
Annual revenue of Samarind is $1.55M as on Dec 31, 2022.
Samarind was founded in 1987 and is based in Deeside, United Kingdom, as part of the Instem group. Operations focus on the life sciences sector and related fields, where software solutions are developed and supplied. The flagship Samarind RMS platform supports regulatory management, while additional tools cover analytics, regulatory tracking, eCTD submissions, license data processing, document management, drug safety monitoring, and ICSR reporting.
Samarind's top competitors include RIMSYS, Sware and ValGenesis.
Samarind has 1 investor. Key investors include Instem.
Samarind operates through Instem Limited.
Yes. Samarind was acquired by Instem in May 2016.